SCHEMBL15601435

SCHEMBL15601435

COCC(=O)Nc1ccc2c(c1)CCCN2Cc1ccc(C(O)(C(F)(F)F)C(F)(F)F)cc1

nearest known ligand 0.49

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 8/20 0.49
EPHX2 P34913 7/20 0.49
KCNT1 Q5JUK3 1/20 0.49
HDAC6 Q9UBN7 10/20 0.46
HDAC1 Q13547 9/20 0.46
HDAC8 Q9BY41 6/20 0.45
HDAC3 O15379 2/20 0.45
HDAC4 P56524 2/20 0.45
HDAC7 Q8WUI4 2/20 0.45
HDAC2 Q92769 2/20 0.45
HDAC11 Q96DB2 2/20 0.45
HDAC9 Q9UKV0 2/20 0.45
HDAC5 Q9UQL6 2/20 0.45
HDAC10 Q969S8 1/20 0.45
NCOR2 Q9Y618 1/20 0.45
CYP2C19 P33261 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15601434 0.94 ALOX5 (0.55) ALOX5EPHX2KCNT1HDAC6HDAC8
SCHEMBL15526096 0.88 ALOX5 (0.52) ALOX5EPHX2KCNT1HDAC6HDAC1
SCHEMBL17154058 0.85 ALOX5 (0.49) ALOX5EPHX2KCNT1HDAC6HDAC1
SCHEMBL15601436 0.84 CES2 (0.45) ALOX5EPHX2KCNT1HDAC6HDAC1
SCHEMBL15612853 0.82 HDAC1 (0.55) HDAC6HDAC1HDAC8HDAC3HDAC4
SCHEMBL15525724 0.82 ALOX5 (0.59) ALOX5EPHX2KCNT1HDAC6HDAC8
SCHEMBL15525722 0.81 HDAC1 (0.47) ALOX5EPHX2KCNT1HDAC6HDAC1
SCHEMBL15601491 0.80 HDAC6 (0.52) ALOX5EPHX2KCNT1HDAC6HDAC1
SCHEMBL17154056 0.80 ALOX5 (0.55) ALOX5EPHX2KCNT1HDAC6HDAC8
SCHEMBL15601465 0.79 ALOX5 (0.52) ALOX5EPHX2KCNT1HDAC6HDAC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9321750-B2 ROR modulators and their uses INNOV17 LLC (US) 2016-04-26 US disclosed
US-9321750-B2 ROR modulators and their uses INNOV17 LLC (US) 2016-04-26 US disclosed
US-20150284366-A1 ROR MODULATORS AND THEIR USES INNOV17 LLC 2015-10-08 US disclosed
US-20150284366-A1 ROR MODULATORS AND THEIR USES INNOV17 LLC 2015-10-08 US disclosed
WO-2013159095-A1 ROR MODULATORS AND THEIR USES GAWECO ANDERSON (US) 2013-10-24 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150284366-A1 ROR MODULATORS AND THEIR USES RORA, RORB, RORC ALOX5 3468/4885EPHX2 926/4885KCNT1 3099/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.